Budesonide 1 MG/2 ML INH susp UD 2ML

Ended Awarded

Contract number
SPE2DB25FKYSY
Awardee
Awarding agency
Obligated
$11,214

Award facts

Contract value 100% obligated
$11,213.65 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Anoka, MN, USA

Award details come from SAM.gov/FPDS.

About this award

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $11,213.65 firm fixed price contract is for the delivery of BUDESONIDE 1 MG/2 ML INH SUSP UD 2ML, a pharmaceutical product. The contract has an ultimate completion date of October 17, 2024 and is part of the DLA Troop Support Medical's ECAT Generation V Program, a large indefinite delivery contract valued at $999,999,999.00 that enables Dakota Drug, Inc. to efficiently deliver a wide range of critical medical items to support U.S. Armed Forces medical operations. This contract award is not designated as a set-aside.

Quick answers

Who was awarded contract SPE2DB25FKYSY?

SPE2DB25FKYSY was awarded to Dakota Drug, Inc. by Defense Logistics Agency (Department of Defense) on October 16, 2024.

How much is contract SPE2DB25FKYSY worth?

The government has obligated $11,214 on SPE2DB25FKYSY.

Is contract SPE2DB25FKYSY an order under another contract?

Yes. SPE2DB25FKYSY is a delivery order under SPE2DB24D8001, an indefinite delivery contract.

Was contract SPE2DB25FKYSY competed?

The extent of competition for SPE2DB25FKYSY was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award